Kevin O’Leary’s Stock Portfolio: Top 5 Stock Picks for 2026

2. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) is one of Kevin O’Leary’s top stock picks for 2026 through the O’Shares U.S. Quality Dividend ETF. The stock made up 5.33% of the ETF as of June 17, 2026. On June 15, 2026, Johnson & Johnson announced an investment of more than $1 billion in Jacksonville, Florida, to expand its Vision manufacturing, packaging, and distribution operations. The project includes advanced manufacturing and packaging technologies, as well as a new distribution facility, aimed at scaling U.S.-based capacity for ACUVUE contact lenses and strengthening supply chain resilience.

The company said the investment is part of its broader $55 billion U.S. commitment to manufacturing, research and development, and technology through early 2029. Construction is already underway, with the facility expected to be fully operational in 2028. The expansion builds on J&J’s more than 40-year presence in Jacksonville, where it says it manufactures more than 1.7 billion ACUVUE lenses annually and supports 3,500 local employees.

Johnson & Johnson (NYSE:JNJ) is a global healthcare company operating through its Innovative Medicine and MedTech segments. Its businesses include pharmaceuticals, medical devices, surgery, orthopedics, cardiovascular technology, and vision care.